Assessment of life habits and health status associated with Fatigue
- Conditions
- Occupational Stress, fatigue.C24.580C23.888.369
- Registration Number
- RBR-7gfj5r
- Lead Sponsor
- niversidade Federal de Ouro Preto
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Workers shortlisted for the high performance operator program according to the company's operational technical criteria will be included in the study
Operators who submit will be excluded:
Evidence of substance abuse or dependence in the last 5 years.
Non-medical psychiatric treatment at least 4 weeks before study.
Clinically significant 24-hour Holter abnormality as complex ventricular arrhythmias, defined as sustained ventricular tachycardia, second-degree mobitz type II or more atrioventricular block, sinus pauses longer than 3 seconds, presence of more than 30 episodes of extrasystoles per hour, and atrial fibrillation or flutter
Decompensated metabolic disorders such as diabetes with glycated hemoglobin (HbA1c) greater than 9% and dyslipidemia with LDL greater than 180 mg / dL or triglycerides greater than 500 mg / dL.
Degenerative chronic diseases (autoimmune, neoplasia, immunodeficient disease and neurological diseases).
Operators with signs and symptoms of infectious diseases.
Gastrointestinal disorders with altered absorption.
Carriers of moderate to severe sleep disorder
Using the following medicines: amitriptyline, clomipramine, imipramine, nortriptyline, fluoxetine, sertraline, paroxetine, venlafaxine, citalopram, lithium carbonate, valproic acid, sodium divalproate, carbamazepine, risperidone, olanzapine, haloperidol, monoaminoxpride inhibitors, moclobemide or selegiline.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method It is expected to find a decrease in fatigue prevalence after the intervention verified by applying the Multidimensional Fatigue Inventory 20 (MFI-20) scale and numerical analog scales (NASs) of chronic fatigue symptoms before and after the experiment.
- Secondary Outcome Measures
Name Time Method It is expected to find increased quality of life after the intervention verified by applying the World Health Organization Quality of Life-36 (WHOQOL-bref) questionnaire before and after the experiment.